{"id":555319,"date":"2026-06-07T22:11:34","date_gmt":"2026-06-07T20:11:34","guid":{"rendered":"https:\/\/medizinonline.com\/les-dermatophytoses-resistantes-a-la-terbinafine-sont-en-augmentation-en-europe-centrale\/"},"modified":"2026-04-23T16:30:18","modified_gmt":"2026-04-23T14:30:18","slug":"les-dermatophytoses-resistantes-a-la-terbinafine-sont-en-augmentation-en-europe-centrale","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/les-dermatophytoses-resistantes-a-la-terbinafine-sont-en-augmentation-en-europe-centrale\/","title":{"rendered":"Les dermatophytoses r\u00e9sistantes \u00e0 la terbinafine sont en augmentation en Europe centrale"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong><em>Trichophyton indotineae (T. indotineae)<\/em> provoque souvent des infections cutan\u00e9es persistantes et r\u00e9currentes et se propage dans le monde entier. Le fait que le nombre de cas ait \u00e9galement augment\u00e9 en Europe centrale au cours des derni\u00e8res ann\u00e9es ressort notamment d&#8217;une \u00e9tude \u00e9pid\u00e9miologique r\u00e9alis\u00e9e en Allemagne. Comme <em>T. indotineae <\/em>entra\u00eene des dermatophytoses r\u00e9sistantes \u00e0 la terbinafine, la d\u00e9tection pr\u00e9coce de l&#8217;agent pathog\u00e8ne par biologie mol\u00e9culaire est d&#8217;une importance capitale. Le m\u00e9dicament actuellement le plus efficace contre les mycoses cutan\u00e9es caus\u00e9es par <em>T. indotineae<\/em> est l&#8217;itraconazole.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-dermatophytoses-resistantes-a-la-terbinafine-sont-en-augmentation-en-europe-centrale%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Trichophyton indotineae (T. indotineae) provoque souvent des infections cutan\u00e9es persistantes et r\u00e9currentes et se propage dans le monde entier. Le fait que le nombre de cas ait \u00e9galement augment\u00e9 en&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-dermatophytoses-resistantes-a-la-terbinafine-sont-en-augmentation-en-europe-centrale%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":555320,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Trichophyton indotineae","footnotes":""},"category":[11549,11349,11362,11527,11428,11510,11535],"tags":[91734,91733,50551,91738,73147,91736,91735,91616,91737,91618],"powerkit_post_featured":[],"class_list":["post-555319","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-allergologie-et-immunologie-clinique","category-dermatologie-et-venerologie","category-etudes","category-infectiologie","category-medecine-tropicale-et-medecine-des-voyages","category-rapports-de-congres","tag-dermatophytoses-resistantes-a-la-terbinafine","tag-detection-de-lagent-pathogene","tag-infections-cutanees","tag-itraconazole","tag-mycoses-de-la-peau","tag-mycoses-de-la-peau-2","tag-t-indotineae","tag-trichophyton-indotineae","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-04 21:01:00","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":555316,"slug":"le-dermatofitosi-resistenti-alla-terbinafina-sono-in-aumento-in-europa-centrale","post_title":"Le dermatofitosi resistenti alla terbinafina sono in aumento in Europa Centrale","href":"https:\/\/medizinonline.com\/it\/le-dermatofitosi-resistenti-alla-terbinafina-sono-in-aumento-in-europa-centrale\/"},"pt_PT":{"locale":"pt_PT","id":555313,"slug":"as-dermatofitoses-resistentes-a-terbinafina-estao-a-aumentar-na-europa-central","post_title":"As dermatofitoses resistentes \u00e0 terbinafina est\u00e3o a aumentar na Europa Central","href":"https:\/\/medizinonline.com\/pt-pt\/as-dermatofitoses-resistentes-a-terbinafina-estao-a-aumentar-na-europa-central\/"},"es_ES":{"locale":"es_ES","id":555310,"slug":"las-dermatofitosis-resistentes-a-la-terbinafina-aumentan-en-europa-central","post_title":"Las dermatofitosis resistentes a la terbinafina aumentan en Europa Central","href":"https:\/\/medizinonline.com\/es\/las-dermatofitosis-resistentes-a-la-terbinafina-aumentan-en-europa-central\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=555319"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555319\/revisions"}],"predecessor-version":[{"id":555321,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555319\/revisions\/555321"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/555320"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=555319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=555319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=555319"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=555319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}